No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Annual revenue · last 1 fiscal years
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
The latest delayed quote for Mobia Medical, Inc. Common Stock (MOBI) stock was $9.31 as of Oct 6, 2026, 11:45 AM EDT, down 2.90% from the previous close.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions.
Medical - Specialties · Austin, TX
Next Earnings Date
N/A
EPS Estimate
N/A
Revenue Est.
N/A
Last Quarter Results
EPS
$-1.10
vs Estimate
$-0.80
Revenue
$13.51M
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1MOBI | $309.62M | $9.31 | -2.90% | N/A | N/A | N/A | N/A |
| 2BNTC | $303.53M | $8.84 | -4.28% | -33.18% | -31.08% | -30.49% | vs MOBI |
| 3RCEL | $318.73M | $12.83 | -3.17% | +138.18% | -5.28% | +4.36% | vs MOBI |
| 4CV | $320.21M | $6.41 | -2.68% | +37.37% | N/A | N/A | vs MOBI |
| 5CCCC | $321.20M | $2.90 | -2.84% | +31.55% | -41.77% | N/A | vs MOBI |
| 6LRMR | $297.62M | $2.87 | +0.17% | -41.12% | -23.91% | -23.59% | vs MOBI |
forward FY estimate
N/A
vs Estimate
$12.17M
Consensus Rating
Based on 4 analysts
Average Price Target
$17.75
+90.6% upside
Low
$16.00
Current
$9.31
High
$19.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.47 | $-0.46 | $-0.45 | 2 |
| Quarter ending Dec 2026 | $-0.56 | $-0.55 | $-0.54 | 2 |
| Quarter ending Mar 2027 | $-0.56 | $-0.55 | $-0.54 | 1 |
| Quarter ending Jun 2027 | $-0.54 | $-0.53 | $-0.53 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-3.55 | $-2.95 | $-2.35 | 3 |
| FY 2027 | $-2.30 | $-2.20 | $-2.11 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $13.88M | $14.03M | $14.24M | 1 |
| Quarter ending Dec 2026 | $15.17M | $15.34M | $15.57M | 2 |
| Quarter ending Mar 2027 | $16.96M | $17.15M | $17.41M | 1 |
| Quarter ending Jun 2027 | $18.43M | $18.64M | $18.92M | 1 |
Annual
| Period |
|---|
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| Low |
|---|
| Avg |
|---|
| High |
|---|
| # Analysts |
|---|
| FY 2026 | $54.62M | $55.04M | $55.84M | 2 |
| FY 2027 | $78.11M | $78.71M | $79.86M | 3 |
